Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
12 pending office actions • 12 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
The University of Delaware manages a highly distributed portfolio with 12 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 12 pending office actions are assigned to 12 distinct examiners across 12 distinct art units. This one-to-one ratio between cases, examiners, and art units indicates that the university's Biotechnology & Pharmaceuticals research is exceptionally diverse, with each active matter falling into a different technical and administrative category.
The prosecution landscape is completely decentralized, as the busiest examiner, AYUB, HINA F, is responsible for only 1 pending office action. This means that no single examiner or department has a concentrated influence over the 12 pending office actions. Practitioners must navigate 12 different sets of examiner preferences and 12 distinct art unit cultures. Maintaining consistency across such a broad spread in the Biotechnology & Pharmaceuticals sector requires a highly adaptable and coordinated strategy, as each of the 12 pending office actions will be subject to unique departmental standards and individual examiner interpretations.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §103 only | 5 (42%) |
| §112 only | 2 (17%) |
| Double-patenting + other | 1 (8%) |
| Multi-statute (no §101) | 3 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AYUB, HINA F | 1 | 85.0% | +17.2% |
| WEARE, MEREDITH H | 1 | 50.5% | +31.4% |
| GRAHAM, CHANTEL LORAN | 1 | 71.8% | +11.5% |
| RAGHU, GANAPATHIRAM | 1 | 73.7% | +26.5% |
| LEONARD, MICHAEL L | 1 | 63.7% | +8.3% |
| SPENCE, JENNIFER SUZANNE | 1 | 66.9% | +46.0% |
| REDDIG, PETER J | 1 | 58.0% | +40.2% |
| CORNELIUS, CLAIRE ADRIENNE | 1 | 71.4% | +0.0% |
| WEBB, WALTER E | 1 | 46.3% | +18.8% |
| GRAHAM, ANDREW D | 1 | 59.8% | +23.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19101051 | SYSTEM AND APPARATUS FOR MEASURING SCATTERED LIGHT SIGNALS FROM PRESSURIZED SOLUTIONS AND METHOD OF ASSEMBLY | AYUB, HINA F | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350357 | FOAM VACCINATION OF AVIANS | CORNELIUS, CLAIRE ADRIENNE | 31d overdue |
| 18131669 | POSITIVE DISPLACEMENT PUMP MATERIAL DELIVERY SYSTEM FOR ADDITIVE MANUFACTURE | GRAHAM, ANDREW D | 28d |
| 18847362 | L-THREONINE TRANSALDOLASES AND USES THEREOF | RAGHU, GANAPATHIRAM | — |
| 17641254 | EX VIVO LYMPH NODE AND USES THEREOF | HUMPHRIES, NICHOLAS ADAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274118 | PREVENTION OF POSTERIOR CAPSULAR OPACIFICATION (PCO) WITH INTEGRIN AVB8 BLOCKING ANTIBODY | REDDIG, PETER J | 12d |
| 18131669 | POSITIVE DISPLACEMENT PUMP MATERIAL DELIVERY SYSTEM FOR ADDITIVE MANUFACTURE | GRAHAM, ANDREW D | 28d |
| 19101051 | SYSTEM AND APPARATUS FOR MEASURING SCATTERED LIGHT SIGNALS FROM PRESSURIZED SOLUTIONS AND METHOD OF ASSEMBLY | AYUB, HINA F | — |
| 18874111 | DEVICES, METHODS, AND SYSTEMS FOR COLLECTING AQUATIC FIELD METABOLIC RATE DATA | WEARE, MEREDITH H | — |
| 18948419 | MICROWAVE-ASSISTED CATALYTIC PYROLYSIS PROCESS AND REACTOR FOR SELECTIVELY CONVERTING ADDITIVE-CONTAINING PLASTIC TO ALKENES AND ALKANES | GRAHAM, CHANTEL LORAN | — |
| 18847362 | L-THREONINE TRANSALDOLASES AND USES THEREOF | RAGHU, GANAPATHIRAM | — |
| 18516243 | NANOPARTICLES AND BIOTEMPLATES WITH TUNABLE LENGTH AND METHODS OF MANUFACTURING THE SAME | SPENCE, JENNIFER SUZANNE | — |
| 18032094 | CELLULAR MEMBRANE VESICLES AND USES THEREOF | WEBB, WALTER E | — |
| Art Unit | Apps |
|---|---|
| 2877 | 1 |
| 3791 | 1 |
| 1771 | 1 |
| 1652 | 1 |
| 1763 | 1 |
| 1633 | 1 |
| 1646 | 1 |
| 1672 | 1 |
| 1612 | 1 |
| 1742 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19101051 | SYSTEM AND APPARATUS FOR MEASURING SCATTERED LIGHT SIGNALS FROM PRESSURIZED SOLUTIONS AND METHOD OF ASSEMBLY | AYUB, HINA F | 2877 | §112 | Non-Final OA | — | Pending | Feb 04, 2025 |
| 18874111 | DEVICES, METHODS, AND SYSTEMS FOR COLLECTING AQUATIC FIELD METABOLIC RATE DATA | WEARE, MEREDITH H | 3791 | §103 | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18948419 | MICROWAVE-ASSISTED CATALYTIC PYROLYSIS PROCESS AND REACTOR FOR SELECTIVELY CONVERTING ADDITIVE-CONTAINING PLASTIC TO ALKENES AND ALKANES | GRAHAM, CHANTEL LORAN | 1771 | §103 | Non-Final OA | — | Pending | Nov 14, 2024 |
| 18847362 | L-THREONINE TRANSALDOLASES AND USES THEREOF | RAGHU, GANAPATHIRAM | 1652 | §103§112 | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18540190 | LIGNIN-DERIVED AND PERFORMANCE-ENHANCED NON-ISOCYANATE POLYURETHANE THERMOSETS | LEONARD, MICHAEL L | 1763 | §103 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18516243 | NANOPARTICLES AND BIOTEMPLATES WITH TUNABLE LENGTH AND METHODS OF MANUFACTURING THE SAME | SPENCE, JENNIFER SUZANNE | 1633 | §102§103DP | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18274118 | PREVENTION OF POSTERIOR CAPSULAR OPACIFICATION (PCO) WITH INTEGRIN AVB8 BLOCKING ANTIBODY | REDDIG, PETER J | 1646 | §103Other | Non-Final OA | 12d | Pending | Jul 25, 2023 |
| 18350357 | FOAM VACCINATION OF AVIANS | CORNELIUS, CLAIRE ADRIENNE | 1672 | §102§103 | Non-Final OA | 31d overdue | Pending | Jul 11, 2023 |
| 18032094 | CELLULAR MEMBRANE VESICLES AND USES THEREOF | WEBB, WALTER E | 1612 | §103 | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18131669 | POSITIVE DISPLACEMENT PUMP MATERIAL DELIVERY SYSTEM FOR ADDITIVE MANUFACTURE | GRAHAM, ANDREW D | 1742 | §102§103§112 | Final Rejection | 28d | Pending | Apr 06, 2023 |
| 17641254 | EX VIVO LYMPH NODE AND USES THEREOF | HUMPHRIES, NICHOLAS ADAM | 1631 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 08, 2022 |
| 16624422 | CAPTURE OF CIRCULATING TUMOR CELLS USING CARBON NANOTUBE SPONGES | BENAVIDES, JENNIFER ANN | 1675 | §112 | Final Rejection | 70d | Pending | Dec 19, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Delaware has 12 pending office actions as of October 2026, spread across 12 art units and 12 examiners.
Hina F Ayub has the most, with 1 of University of Delaware's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
